Xoft
Xoft Home   |   Patients Home   
HomeBreast eBxGyn eBxSkin eBx

What Should I Expect?

One in six people will develop skin cancer at some point in their lives, with over a million cases annually in the U.S. Most patients are diagnosed with non-melanoma skin cancer (NMSC) with basal cell carcinoma being the most common in 80% and squamous cell carcinoma representing 20%. The majority of lesions are located on sun-exposed areas like face, the back of hands and neck.

Surgical excision is the most common skin cancer treatment, but in certain patients primary or postoperative radiotherapy can be an ideal alternative, with excellent cosmetic results.

Unlike alternative brachytherapy procedures, which use radioactive isotopes, the Axxent® eBx™ System uses a nonradioactive electronic X-ray source.

See patient brochure for more information.